Evidence for strong mutation bias towards, and selection against, U content in SARS-CoV-2: implications for vaccine design

Laurence Hurst, Atahualpa Castillo Morales, Alex Ho, Stefanie Mühlhausen, Christine Mordstein, Alan M. Rice

Research output: Contribution to journalArticlepeer-review

48 Citations (SciVal)


Large-scale re-engineering of synonymous sites is a promising strategy to generate vaccines either through synthesis of attenuated viruses or via codon optimized genes in DNA vaccines. Attenuation typically relies on de-optimisation of codon pairs and maximization of CpG dinucleotide frequencies. So as to formulate evolutionarily-informed attenuation strategies that aim to force nucleotide usage against the direction favoured by selection, here we examine available whole-genome sequences of SARS-CoV-2 to infer patterns of mutation and selection on synonymous sites. Analysis of mutational profiles indicates a strong mutation bias towards U. In turn, analysis of observed synonymous site composition implicates selection against U. Accounting for dinucleotide effects reinforces this conclusion, observed UU content being a quarter of that expected under neutrality. Possible mechanisms of selection against U mutations includes selection for higher expression, for high mRNA stability or lower immunogenicity of viral genes. Consistent with gene-specific selection against CpG dinucleotides, we observe systematic differences of CpG content between SARS-CoV-2 genes. We propose an evolutionarily-informed approach to attenuation that, unusually, seeks to increase usage of the already most common synonymous codons. Comparable analysis of H1N1 and Ebola finds that GC3 deviated from neutral equilibrium is not a universal feature, cautioning against generalization of results.
Original languageEnglish
Pages (from-to)67-83
JournalMolecular Biology and Evolution
Issue number1
Early online date20 Jul 2020
Publication statusPublished - 31 Jan 2021


Dive into the research topics of 'Evidence for strong mutation bias towards, and selection against, U content in SARS-CoV-2: implications for vaccine design'. Together they form a unique fingerprint.

Cite this